Skip to main content
. 2022 Dec 15;10(12):2149. doi: 10.3390/vaccines10122149
PL-NAb (BAU/mL) Outcome
0–50 Negative for NAb
51–100 Borderline or low positive for NAb (not protected)
101–1000 Moderately protective immunity
>1000 Fully protected (in terms of SARS-CoV-2 disease severity)